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Background: Chronic total occlusion (CTO) intervention is still challenging because
of the limited procedural success rate and high target failure. The impact of percu-
taneous coronary intervention (PCI) for CTO in patients (pts) with non-LAD disease is
not clear. We evaluated the 12-month clinical outcomes between PCI and optimal
medical therapy (OMT) for CTO lesions in pts with non-LAD disease.
Methods: A total of 406 consecutive CTO pts were divided into 2 groups according to
treatment strategy; PCI group (n¼154) and OMT group (n¼252). Major clinical
outcomes were compared between the two groups up to 12 months.
Results: At baseline, patients in the OMT group had a lower left ventricular ejection
fraction and a higher prevalence of male gender, elderly, stroke, de novo disease, left
main disease, multivessel disease, and well-developed collateral vessels (grade 2),
whereas the PCI group had a higher prevalence of prior MI, prior PTCA, prior CABG
and single-vessel CTO disease. Clinical outcomes at 12 months showed lower mor-
tality, lower incidence of overall MI and Q wave MI in the PCI group (Table). After
baseline adjustment by multivariate analysis, there was no difference between the 2
groups.
Conclusion: In our study, PCI seems to have no deﬁnite beneﬁt over OMT in
reducing 12-month hard endpoints in patients with non-LAD CTO. Long-term follow
up with larger study population will be necessary for further clariﬁcation.TCTAP A-162
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Background: Chronic total occlusion (CTO) intervention is still challenging because
of the limited procedural success rate and high target failure. The impact of percu-
taneous coronary intervention (PCI) for CTO in patients (pts) who have received PCI
for non-CTO lesions is not clear. We evaluated the 12-month clinical outcomes be-
tween intervention and optimal medical therapy (OMT) for CTO lesions in these pts.
Methods: A total of 273 consecutive CTO pts who have received non-target lesion
PCI were divided into 2 groups according to treatment strategy; PCI group (n¼114)
and the OMT (n¼159). Major clinical outcomes were compared between the two
groups up to 12 months.
Results: A total of 273 consecutive CTO pts who have received non-target lesion PCI
were divided into 2 groups according to treatment strategy; PCI group (n¼114) and
the OMT (n¼159). Major clinical outcomes were compared between the two groups
up to 12 months.
Conclusion: In our study, intervention shows a possibility of being a favorable choice
of therapy for CTO lesions in terms of lower non-Q wave MI occurrence and all
MACE at 12 months in patients who underwent non-target lesion PCI. Long-term
follow up with larger study population will be necessary for further clariﬁcation.S46 JACC Vol 63/12/Suppl S j AprTCTAP A-163
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Background: Limited coronary collateral ﬂow is known to have an adverse effect on
clinical outcomes of coronary artery diseases. The impact of percutaneous coronary
intervention (PCI) for chronic total occlusion (CTO) in pts with limited collaterals is
not clear. We compared the 12-month clinical outcomes of pts treated by PCI with
optimal medical therapy (OMT) for CTO lesions in pts with limited collaterals.
Methods: A total of 166 consecutive CTO pts with coronary collateral ﬂow grade <2
were divided into 2 groups; one group underwent PCI (PCI group; n¼100) and the
other group was treated with OMT (OMT group; n¼66). Major clinical outcomes
were compared between the two groups up to 12 months.
Results: At baseline, the OMT group had a lower LVEF% and a higher prevalence of
elderly, left main disease, multivessel disease, multivessel CTO, and LCX-CTO,
whereas the PCI group had a higher prevalence of prior MI and prior PTCA. Clinical
outcomes at 12 months showed higher incidence of non Q-wave MI in the OMT group
(Table). After baseline adjustment by multivariate analysis, however, there was no
difference between the 2 groups.
Conclusion: In our study, mechanical revascularization by PCI for CTO lesions in pts
with limited collaterals seems to have no deﬁnite beneﬁt in reducing 12-month
morbidity or mortality. Long-term follow up with larger study population will be
necessary for further determination of the beneﬁt and risks of interventional therapy in
CTO pts.il 22–25, 2014 j TCTAP Abstracts/POSTER/Chronic Total Occlusions
